Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 335

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts

Open access
Pabinger, Ingrid, van Es, Nick, Heinze, Georg, Posch, Florian, Riedl, Julia, Reitter, Eva-Maria, Di Nisio, Marcello, Cesarman-Maus, Gabriela, Kraaijpoel, Noémie, Zielinski, Christoph Carl, Büller, Harry Roger, Ay, Cihan·2018·The Lancet Haematology

Abstract

BACKGROUND: Venous thromboembolism is a common complication of cancer, but the risk of developing venous thromboembolism varies greatly among individuals and depends on numerous factors, including type of cancer. We aimed to develop and externally validate a clinical prediction model for cancer-associated venous thromboembolism. METHODS: We used data from the prospective Vienna Cancer and Thrombosis Study (CATS) cohort (n=1423) to select prognostic variables for inclusion in the model. We then validated the model in the prospective Multinational Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism (MICA) cohort (n=832). We calculated c-indices to show how the predicted incidence of objectively confirmed venous thromboembolism at 6 months compared with the cumulative 6-month incidences observed in both cohorts. FINDINGS: Two variables were selected for inclusion in the final clinical prediction model: tumour-site risk category (low or intermediate vs high vs very high) and continuous D-dimer concentrations. The multivariable subdistribution hazard ratios were 1·96 (95% CI 1·41-2·72; p=0·0001) for high or very high versus low or intermediate and 1·32 (95% CI 1·12-1·56; p=0·001) per doubling of D-dimer concentration. The cross-validated c-indices of the final model were 0·66 (95% CI 0·63-0·67) in CATS and 0·68 (0·62-0·74) in MICA. The clinical prediction model was adequately calibrated in both cohorts. INTERPRETATION: An externally validated clinical prediction model incorporating only one clinical factor (tumour-site category) and one biomarker (D-dimer) predicted the risk of venous thromboembolism in ambulatory patients with solid cancers. This simple model is a considerable improvement on previous models for predicting cancer-associated venous thromboembolism, and could aid physicians in selection of patients who will likely benefit from thromboprophylaxis. FUNDING: Austrian Science Fund, Austrian National Bank Memorial Fund, and participating hospitals.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2352-3026(18)30063-2

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 335

Metadata

Authors
Pabinger, I., van Es, N., Heinze, G., Posch, F., Riedl, J., Reitter, E.-M., Di Nisio, M., Cesarman-Maus, G., Kraaijpoel, N., Zielinski, C. C., Büller, H. R., & Ay, C.
Venue
The Lancet Haematology
Publisher
Elsevier BV
Published
2018-07
Volume
5
Issue
7
Pages
e289-e298
ISSN
2352-3026 (ISSN-L)
OpenAlex
W2807617068
Cited by
335
References
31
FWCI
31.01
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. https://app.cochat.ai/papers/10.1016/s2352-3026(18)30063-2
The paper
Pabinger, I., van Es, N., Heinze, G., Posch, F., Riedl, J., Reitter, E.-M., Di Nisio, M., Cesarman-Maus, G., Kraaijpoel, N., Zielinski, C. C., Büller, H. R., & Ay, C. (2018). A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts. The Lancet Haematology. https://doi.org/10.1016/s2352-3026(18)30063-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.